What is the California v. Texas (Texas v. Azar/U.S.) lawsuit?
California v. Texas was a lawsuit that was initially filed by 20 GOP-led states in early 2018, seeking to overturn the Affordable Care Act. The case was dismissed by the Supreme Court in June 2021, in a 7-2 ruling. This marked the third time the ACA was upheld by the Supreme Court (the previous two opinions were issued in 2012 and 2015).
When the case began, in early 2018, it was called Texas v. Azar. But after two lower court rulings, California – the lead Democratic state working to protect the ACA – filed a petition in early 2020 asking the Supreme Court to hear the case on an expedited schedule. Texas, the lead Republican state seeking to overturn the ACA, also filed a petition with the Supreme Court, asking the justices to deny California’s request for an expedited review but to eventually hear the case.
Ultimately, the Supreme Court agreed to hear the case, but in the 2020-2021 term rather than the 2019-2020 term. The two petitions, from California and Texas, were combined into the case that was called California v. Texas, and the Supreme Court heard oral arguments on November 10, 2020, shortly after Justice Amy Coney Barrett was confirmed and Joe Biden won the presidential election.
Two states that were initially working with Texas on this case – Wisconsin and Maine – subsequently withdrew from the suit after Democratic governors took office, but 18 GOP-led states continued to challenge the ACA in this case. In addition, two individuals from Texas were plaintiffs in the case.
Californa v. Texas history
The case was filed (by Texas and 19 other states) soon after the Tax Cuts and Jobs Act reduced the ACA’s individual mandate penalty/tax to $0 (that provision took effect in 2019, but it was enacted in late 2017). The plaintiffs’ argument in Texas v. Azar hinged on the Supreme Court’s ruling in 2012 that the ACA’s individual mandate was constitutional because it was enforced with a tax and thus allowed under the federal government’s powers of taxation.
Without that tax, the plaintiffs in Texas v. Azar argued that the individual mandate was not constitutional after all. And they also argued that the mandate was not severable from the rest of the ACA, meaning that the entire law should be overturned. Legal scholars called this interpretation “absurd,” but a federal judge sided with the plaintiffs in late 2018, ruling that the ACA should be overturned.
The case was appealed, and the U.S. Department of Justice initially supported the appeal (as is typical when a federal law is being challenged; the Department of Justice normally defends federal statute). But the DOJ’s position changed over time: By March 2019, the federal government agreed with the plaintiff states that the entire ACA should be overturned, and later argued that some ACA provisions should be allowed to survive (but not the law’s protections for people with pre-existing conditions). During the oral arguments in the 5th Circuit Court of Appeals in 2019, the federal government called for the ACA to only be overturned in the plaintiff states. Then in June 2020, the Trump administration filed a brief in support of the argument that Texas was making: That the individual mandate is unconstitutional, and the entire ACA should thus be overturned.
Oral arguments were heard in the 5th Circuit Court of Appeals in July 2019, and a ruling was issued in December 2019. But the ruling amounted to a delay: The panel of judges agreed with the lower court that the ACA’s individual mandate was unconstitutional, but they sent the case back to the lower court for a specific list of the ACA provisions that should thus be overturned (the lower court had previously ruled that the entire ACA should be overturned).
This delay caused additional uncertainty for insurers and consumers in the individual health insurance market, and pushed the case out past the 2020 elections. A group of Democratic-led states and the U.S. House of Representatives asked the Supreme Court to step in and hear the case in the 2020 term, without waiting for an update from the lower court regarding the portions of the ACA that should be overturned.
The Supreme Court initially declined that request, but later agreed to hear the case before it would otherwise have made its way there — the case (19-840) appeared on the Court’s order list as of March 2020, and oral arguments took place in November 2020, a week after the election. A 7-2 ruling was handed down in June 2021, dismissing the case.
The defense of the ACA in Texas v. Azar was led by attorneys general from Democratic-led states, since the federal government, led by the Trump administration, mostly declined to defend the ACA. That changed soon after President Biden took office, with the DOJ officially reversing the previous administration’s position on the case, but there were no more arguments or filings due in the case at that point, and all that was left was for the Court to issue its ruling.
Although the ACA was upheld by the Supreme Court in 2012 and 2015, the makeup of the Court was different in 2020/2021, as it included three Trump appointees. Nevertheless, the court’s support for upholding the ACA grew stronger with each challenge: Despite the fact that the court was more conservative than it had been a decade earlier, the 2021 ruling was 7-2, whereas the 2012 ruling to uphold the ACA had been a 5-4 vote, and the 2015 ruling was a 6-3 vote (the arguments and merits of the various cases also differed).
Ironically, some of the original plaintiff states had been working to implement laws and regulations to protect their citizens from a potential overturn of the ACA — despite the fact that they were simultaneously working to overturn the ACA. But without the ACA’s federal funding, including funding for premium subsidies and Medicaid expansion, few — if any — states would have been able to replicate the ACA’s level of coverage and affordability.
